These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 18367383)
21. Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis. Wiederhold NP; Fothergill AW; McCarthy DI; Tavakkol A Antimicrob Agents Chemother; 2014 Jun; 58(6):3553-5. PubMed ID: 24709260 [TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes. Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461 [TBL] [Abstract][Full Text] [Related]
23. In vitro activity of terbinafine against clinical isolates of dermatophytes. Arzeni D; Barchiesi F; Compagnucci P; Cellini A; Simonetti O; Offidani AM; Scalise G Med Mycol; 1998 Aug; 36(4):235-7. PubMed ID: 9776840 [TBL] [Abstract][Full Text] [Related]
24. In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes. Simonetti O; Arzeni D; Ganzetti G; Silvestri C; Cirioni O; Gabrielli E; Castelletti S; Kamysz W; Kamysz E; Scalise G; Offidani A; Barchiesi F Br J Dermatol; 2009 Aug; 161(2):249-52. PubMed ID: 19438437 [TBL] [Abstract][Full Text] [Related]
25. In vitro activity of Tachyplesin III alone and in combination with terbinafine against clinical isolates of dermatophytes. Simonetti O; Ganzetti G; Arzeni D; Campanati A; Marconi B; Silvestri C; Cirioni O; Gabrielli E; Lenci I; Kamysz W; Kamysz E; Giacometti A; Scalise G; Barchiesi F; Offidani A Peptides; 2009 Oct; 30(10):1794-7. PubMed ID: 19591887 [TBL] [Abstract][Full Text] [Related]
27. Antidermatophytic activity of allylamine derivatives. Venugopal PV; Venugopal TV Indian J Pathol Microbiol; 1994 Oct; 37(4):381-8. PubMed ID: 7868170 [TBL] [Abstract][Full Text] [Related]
28. In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes. Santos DA; Hamdan JS Med Mycol; 2006 Jun; 44(4):357-62. PubMed ID: 16772230 [TBL] [Abstract][Full Text] [Related]
29. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan. Chadeganipour M; Nilipour S; Havaei A Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457 [TBL] [Abstract][Full Text] [Related]
30. Comparison of the in vitro activity of terbinafine and lanoconazole against dermatophytes. Ghannoum MA; Welshenbaugh A; Imamura Y; Isham N; Mallefet P; Yamaguchi H Mycoses; 2010 Jul; 53(4):311-3. PubMed ID: 19422522 [TBL] [Abstract][Full Text] [Related]
31. Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. Oz Y; Qoraan I; Oz A; Balta I Int J Dermatol; 2017 Jan; 56(1):68-74. PubMed ID: 27667305 [TBL] [Abstract][Full Text] [Related]
32. In vitro susceptibility testing of dermatophytes: comparison of disk diffusion and reference broth dilution methods. Karaca N; Koç AN Diagn Microbiol Infect Dis; 2004 Apr; 48(4):259-64. PubMed ID: 15062918 [TBL] [Abstract][Full Text] [Related]
33. Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay. Koc AN; Silici S; Ayangil D; Ferahbaş A; Cankaya S Mycoses; 2005 May; 48(3):205-10. PubMed ID: 15842339 [TBL] [Abstract][Full Text] [Related]
34. Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs. Torres-Rodríguez JM; Madrenys-Brunet N; Siddat M; López-Jodra O; Jimenez T J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):25-31. PubMed ID: 9731962 [TBL] [Abstract][Full Text] [Related]
35. Effect of Lamisil and azole antifungals in experimental nail infection. Richardson MD Dermatology; 1997; 194 Suppl 1():27-31. PubMed ID: 9154398 [TBL] [Abstract][Full Text] [Related]
37. Itraconazole and terbinafine in perspective. From petri dish to patient. De Doncker P; Gupta AK Postgrad Med; 1999 Jul; Spec No():6-11. PubMed ID: 10492660 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes. Castro C; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E Chemotherapy; 2008; 54(6):427-30. PubMed ID: 18824849 [TBL] [Abstract][Full Text] [Related]
39. In vitro activity of Phytolacca dodecandra (Endod) against dermatophytes. Woldeamanuel Y; Abate G; Chryssanthou E Ethiop Med J; 2005 Jan; 43(1):31-4. PubMed ID: 16370528 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A). Barros MEDS; Santos DA; Hamdan JS J Med Microbiol; 2007 Apr; 56(Pt 4):514-518. PubMed ID: 17374893 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]